GLP-1 / Weight Management
Incretin-based peptides and metabolic research compounds including GLP-1, dual, and triple receptor agonists for glucose and weight regulation studies.
14 products available
Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.
Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.
Retatrutide
A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.
Liraglutide
A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.
Cagrilintide
A long-acting amylin analog researched for its effects on satiety signaling and energy balance. Often studied alongside GLP-1 agonists in combination protocols.
Cagrisema (2.5mg + 2.5mg)
A combination of cagrilintide and semaglutide in a single vial. Studied for potential synergistic effects on metabolic pathways through dual amylin/GLP-1 receptor activation.
Retatrutide 20mg + Tirzepatide 40mg
A combination blend of retatrutide and tirzepatide in a 10ml vial. Designed for research into multi-receptor agonist synergy across GIP, GLP-1, and glucagon pathways.
Survodutide
A dual glucagon/GLP-1 receptor agonist under investigation for metabolic disorders. Studied for its potential effects on hepatic lipid metabolism and energy expenditure.
Mazdutide
A dual GLP-1/glucagon receptor agonist being researched for metabolic regulation. Investigated for its effects on body composition and glycemic parameters.
Dulaglutide
A long-acting GLP-1 receptor agonist fused to an Fc fragment for extended duration. Researched for sustained glucose regulation and metabolic pathway studies.
AOD9604
A modified fragment of human growth hormone (HGH 176-191) studied for its lipolytic properties. Researched for fat metabolism without the growth-promoting effects of full-length HGH.
SLU-PP-322
A novel research compound studied for its potential role in metabolic regulation and energy balance pathways.
Adipotide/FTTP
A peptidomimetic that targets prohibitin on the vasculature of adipose tissue. Studied in preclinical models for its effects on adipose tissue blood supply.
FTPP Adipotide
Fat-targeted proapoptotic peptide variant studied in adipose tissue remodeling research. Investigated for selective action on white adipose vasculature.